Letters

Hepatitis B vaccination

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7033.777b (Published 23 March 1996) Cite this as: BMJ 1996;312:777

Information for patients is vital

  1. Anna Pallecaros,
  2. Angela Robinson
  1. Clinical research fellow Department of Genitourinary Medicine, St Mary's Hospital, London W2 1NY
  2. Consultant physician Department of Genitourinary Medicine, University College Hospital, London WC1E 6AU

    EDITOR,—P Mantagni and colleagues highlight the need to improve access to hepatitis B vaccination within services for intravenous drug users.1 Experience of vaccination in genitourinary medicine clinics, which offer an established access point for target groups, has shown that access is only one part of the process of effective vaccination.2 It is vital that services offering the vaccine provide effective information for patients and monitor participants from initial to final vaccination. We present audit data showing …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe